期刊文献+

房颤患者左心房内径与血清骨保护素及其受体轴的关系及临床意义 被引量:6

Correlative study on relationship between serum OPG/RANKL Axis and left atrial diameter in atrial fibrillation patients
原文传递
导出
摘要 心房颤动(房颤)是临床上最常见的心律失常,其发病率在全世界范围内具有增高趋势,房颤有导致和加重心力衰竭以及增加血管栓塞的风险。但房颤的发病机制并未完全清楚,近年来研究发现,房颤的发生和维持与心房的电重构和结构重构有一定关系,特别是与心房纤维化、心房肌细胞的凋亡及炎症反应有密切关系[1], We detect the levels of OPG/RANKL in serum using ELISA in 22 patients with paroxysmal atrial fibrillation(AF),22 patients with permanent AF and 40 patients with sinus rhythm.The levels of OPG/RANKL in patients with permanent AF were statistically higher than that in paroxysmal AF or sinus rhythm controls and the LADs in patients with permanent AF were statistically higher than that in paroxysmal AF or sinus rhythm controls.The levels of OPG/RANKL in patients with paroxysmal AF were statistically higher than in sinus rhythm controls,but,the LADs in patients with paroxysmal AF were't statistically higher than that in sinus rhythm controls.Our results suggest that OPG/RANKL may participate in the occurrence and persistence of AF.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2015年第3期334-336,共3页 Journal of Clinical Cardiology
关键词 心房颤动 骨保护素 左心房内径 atrial fibrillation OPG/RANKL left atrial diameter
  • 相关文献

参考文献9

  • 1KO W C, HONG C Y,HOU S M,et al. Elevated ex- pression of connective tissue growth factor in human atrial fibrillation and angiotensin Ⅱ-treated cardio- myocytes[J]. Circ J, 2011,75 : 1592 - 1600.
  • 2NDIP A, WILLIAMS A, JUDE E B, et al. The RANKL/RANK/OPG signaling pathway mediates medial arterial calcification in diabetic Charcot neuro- arthropathy[J]. Diabetes, 2011,60 : 2187 - 2196.
  • 3UELAND T, YNDESTAD A, OIE E, et al. Dysregu- lated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure[J]. Circulation, 2005,111:2461-2468.
  • 4CAO H, WANG J, XI L, et al. Dysregulated atrial gene expression of osteoprotegerin /receptor activator of nuclear factor-κB (RANK) /RANK ligand axis in the development and progression of atrial fibrillation [J]. Circ J,2011,75:2781-2788.
  • 5CONWAY D S, BUGGINS P, HUGHES E, et al. Prognostic significance of raised plasma levels of inter- leukin-6 and C-reactive protein in atrial fibrillation[J]. Am Heart J,2004,148:462-466.
  • 6李朝亮,李凌,陶海龙.心房颤动患者射频消融术前、术后超敏C-反应蛋白的变化[J].中国实用医刊,2011,38(4):75-76. 被引量:1
  • 7SIMONET W S,LACEY D L,DUNSTAN C R,et al. Osteoprotegerin:a novel secreted protein involved in the regulation of bone density[J]. Cell, 1997,89:309- 319.
  • 8BLAZQUEZ-MEDELA A, LOPEZ-NOVOA J, MAR- TINEZ-SALGADO C, et al. Osteoprotegerin andDia- betes-Associated Pathologies [J]. Curt Mol Med, 2011 :401-416.
  • 9HALAPAS A, ZACHAROULIS A, THEOCHARIS S,et al. Serum levels of the osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, metallopro- teinase-1 (MMP-1) and tissue inhibitors of MMP-1 levels are increased in men 6 months after acute myo- cardial infarction[J]. Clin Chem Lab Med, 2008,46: 510-516.

同被引文献59

引证文献6

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部